Madhav V. Dhodapkar MBBS

Professor and Anise McDaniel Brock Chair, Hematology & Medical Oncology

Emory University School of Medicine

Georgia Research Alliance Eminent Scholar in Cancer Innovation

Emory University School of Medicine

Winship Center for Cancer Immunology

Winship Cancer Institute of Emory University

Office: Emory Health Sciences Research Building


For all patient inquiries or appointment requests, please dial (404) 778-1900. Fax patient records to (404) 778-2177.


A board certified hematologist and medical oncologist, Madhav V. Dhodapkar, MBBS, specializes in the treatment of multiple myeloma and other hematological malignancies. An internationally recognized immunobiologist, Dr. Dhodapkar is working to harness the properties of the immune system to detect, prevent and treat cancer, with a particular focus on multiple myeloma. His primary clinical and scholarly focus is the immuno-biology of myeloma and the development of novel biological approaches to treat cancer. He serves as director of the Winship Center for Cancer Immunology.

Prior to joining Emory, he served as Chief of Hematology, the Arthur H. and Isabel Bunker Professor of Medicine (Hematology), and Professor of Immunobiology at Yale University School of Medicine. An expert in the treatment of multiple myeloma, he also was co-director of the Cancer Immunology Program within the Yale Cancer Center. Other faculty appointments include Myeloma Institute in Little Rock, Arkansas, Memorial Sloan Kettering Cancer Center in New York, New York, and The Rockefeller University in New York, New York.

Dr. Dhodapkar received his Medical Degree from the All India Institute of Medical Sciences in New Delhi. He completed his residency in internal medicine at St. Louis University, and his fellowship in hematology and medical oncology at the Mayo Clinic in Rochester, Minnesota.

Full Clinical Bio >>


Dr. Dhodapkar is credited with helping to define the role of the immune system in controlling early cancer cells. His research focuses on how the immune system regulates the progression from precursor lesions to cancer as well as the mechanisms of treatment sensitivity and resistance to cancer immunotherapy.

Dr. Dhodapkar has authored over 100 scientific publications and is section editor for the Journal of Immunology, and associate editor for Blood.